Suppr超能文献

KCNJ5基因两个新的种系突变在无原发性醛固酮增多症但有促肾上腺皮质激素依赖性醛固酮分泌过多的高血压患者中的功能特征。

Functional characterization of two novel germline mutations of the KCNJ5 gene in hypertensive patients without primary aldosteronism but with ACTH-dependent aldosterone hypersecretion.

作者信息

Sertedaki Amalia, Markou Athina, Vlachakis Dimitrios, Kossida Sophia, Campanac Emilie, Hoffman Dax A, Sierra Maria De La Luz, Xekouki Paraskevi, Stratakis Constantine A, Kaltsas Gregory, Piaditis George P, Chrousos George P, Charmandari Evangelia

机构信息

Division of Endocrinology, Metabolism and Diabetes, First Department of Pediatrics, National and Kapodistrian University of Athens Medical School, 'Aghia Sophia' Children's Hospital, Athens, Greece.

Department of Endocrinology and Diabetes Center, 'G. Gennimatas' General Hospital, Athens, Greece.

出版信息

Clin Endocrinol (Oxf). 2016 Dec;85(6):845-851. doi: 10.1111/cen.13132. Epub 2016 Jul 12.

Abstract

BACKGROUND

Germline mutations of the KCNJ5 gene encoding Kir3·4, a member of the inwardly rectifying K channel, have been identified in 'normal' adrenal glands, patients with familial hyperaldosteronism (FH) type III, aldosterone-producing adenomas (APAs) and sporadic cases of primary aldosteronism (PA).

OBJECTIVE

To present two novel KCNJ5 gene mutations in hypertensive patients without PA, but with Adrenocorticotropic hormone (ACTH)-dependent aldosterone hypersecretion.

DESIGN AND PATIENTS

Two hypertensive patients without PA, who exhibited enhanced ACTH-dependent response of aldosterone secretion, underwent genetic testing for the presence of the CYP11B1/CYP11B2 chimeric gene and KCNJ5 gene mutations. Genomic DNA was isolated from peripheral white blood cells, and the exons of the entire coding regions of the above genes were amplified and sequenced. Electrophysiological studies were performed to determine the effect of identified mutation(s) on the membrane reversal potentials. Structural biology studies were also carried out.

RESULTS

Two novel germline heterozygous KCNJ5 mutations, p.V259M and p.Y348N, were detected in the two subjects. Electrophysiological studies showed that the Y348N mutation resulted in significantly less negative reversal potentials, suggesting loss of ion selectivity, while the V259M mutation did not affect the Kir3.4 current. In the mutated structural biology model, the N348 mutant resulted in significant loss of the ability for hydrogen bonding, while the M259 mutant was capable of establishing weaker interactions. The CYP11B1/CYP11B2 chimeric gene was not detected.

CONCLUSIONS

These findings expand on the clinical spectrum of phenotypes associated with KCNJ5 mutations and implicate these mutations in the pathogenesis of hypertension associated with increased aldosterone response to ACTH stimulation.

摘要

背景

在“正常”肾上腺、Ⅲ型家族性醛固酮增多症(FH)患者、醛固酮瘤(APA)及散发性原发性醛固酮增多症(PA)病例中,已发现编码内向整流钾通道成员Kir3·4的KCNJ5基因的种系突变。

目的

呈现两例无PA但有促肾上腺皮质激素(ACTH)依赖性醛固酮分泌增多的高血压患者中的两个新的KCNJ5基因突变。

设计与患者

两名无PA的高血压患者,其醛固酮分泌呈现增强的ACTH依赖性反应,接受了CYP11B1/CYP11B2嵌合基因和KCNJ5基因突变检测。从外周白细胞中分离基因组DNA,对上述基因整个编码区的外显子进行扩增和测序。进行电生理研究以确定所鉴定突变对膜反转电位的影响。还开展了结构生物学研究。

结果

在两名受试者中检测到两个新的种系杂合KCNJ5突变,即p.V259M和p.Y348N。电生理研究表明,Y348N突变导致反转电位显著降低负值,提示离子选择性丧失,而V259M突变不影响Kir3.4电流。在突变的结构生物学模型中,N348突变体导致氢键形成能力显著丧失,而M259突变体能够建立较弱的相互作用。未检测到CYP11B1/CYP11B2嵌合基因。

结论

这些发现扩展了与KCNJ5突变相关的临床表型谱,并提示这些突变与ACTH刺激下醛固酮反应增加相关的高血压发病机制有关。

相似文献

2
Stress-induced Aldosterone Hyper-Secretion in a Substantial Subset of Patients With Essential Hypertension.
J Clin Endocrinol Metab. 2015 Aug;100(8):2857-64. doi: 10.1210/jc.2015-1268. Epub 2015 May 14.
3
Aldosterone-Regulating Receptors and Aldosterone-Driver Somatic Mutations.
Front Endocrinol (Lausanne). 2021 Mar 16;12:644382. doi: 10.3389/fendo.2021.644382. eCollection 2021.
4
Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
Hypertension. 2014 Jan;63(1):188-95. doi: 10.1161/HYPERTENSIONAHA.113.01733. Epub 2013 Sep 30.
5
a Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III.
J Clin Endocrinol Metab. 2013 Nov;98(11):E1861-5. doi: 10.1210/jc.2013-2428. Epub 2013 Sep 13.
6
Double CYP11B1/CYP11B2 Immunohistochemistry and Detection of KCNJ5 Mutations in Primary Aldosteronism.
J Clin Endocrinol Metab. 2024 Sep 16;109(10):2433-2443. doi: 10.1210/clinem/dgae411.
7
Genetic, Cellular, and Molecular Heterogeneity in Adrenals With Aldosterone-Producing Adenoma.
Hypertension. 2020 Apr;75(4):1034-1044. doi: 10.1161/HYPERTENSIONAHA.119.14177. Epub 2020 Mar 2.
8
Different cell compositions and a novel somatic variant found in a patient with bilateral adrenocortical adenomas secreting aldosterone and cortisol.
Front Endocrinol (Lausanne). 2023 Mar 7;14:1068335. doi: 10.3389/fendo.2023.1068335. eCollection 2023.
9
Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas.
Mol Cell Endocrinol. 2015 Aug 15;411:146-54. doi: 10.1016/j.mce.2015.04.022. Epub 2015 May 6.

引用本文的文献

1
O tempora, o mores: The Age We Live In, Machine Learning, Hypertension, and Primary Aldosteronism.
JACC Asia. 2023 Aug 15;3(4):676-677. doi: 10.1016/j.jacasi.2023.06.005. eCollection 2023 Aug.
2
Unravelling the Genetic Basis of Primary Aldosteronism.
Nutrients. 2021 Mar 8;13(3):875. doi: 10.3390/nu13030875.
3
Cushing Syndrome in a Pediatric Patient With a KCNJ5 Variant and Successful Treatment With Low-dose Ketoconazole.
J Clin Endocrinol Metab. 2021 May 13;106(6):1606-1616. doi: 10.1210/clinem/dgab118.
5
An update on adrenal endocrinology: significant discoveries in the last 10 years and where the field is heading in the next decade.
Hormones (Athens). 2018 Dec;17(4):479-490. doi: 10.1007/s42000-018-0072-y. Epub 2018 Nov 19.
6
Familial hyperaldosteronism type III.
J Hum Hypertens. 2017 Dec;31(12):776-781. doi: 10.1038/jhh.2017.34. Epub 2017 Apr 27.

本文引用的文献

1
GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation.
J Chem Theory Comput. 2008 Mar;4(3):435-47. doi: 10.1021/ct700301q.
2
Stress-induced Aldosterone Hyper-Secretion in a Substantial Subset of Patients With Essential Hypertension.
J Clin Endocrinol Metab. 2015 Aug;100(8):2857-64. doi: 10.1210/jc.2015-1268. Epub 2015 May 14.
3
Regulation of aldosterone biosynthesis by the Kir3.4 (KCNJ5) potassium channel.
Clin Exp Pharmacol Physiol. 2013 Dec;40(12):895-901. doi: 10.1111/1440-1681.12151.
4
Role of KCNJ5 in familial and sporadic primary aldosteronism.
Nat Rev Endocrinol. 2013 Feb;9(2):104-12. doi: 10.1038/nrendo.2012.230. Epub 2012 Dec 11.
5
A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension.
J Clin Endocrinol Metab. 2012 Aug;97(8):E1532-9. doi: 10.1210/jc.2012-1334. Epub 2012 May 24.
7
Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5.
Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2533-8. doi: 10.1073/pnas.1121407109. Epub 2012 Jan 30.
8
KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism.
Hypertension. 2012 Feb;59(2):235-40. doi: 10.1161/HYPERTENSIONAHA.111.183996. Epub 2011 Dec 27.
9
A diagnostic algorithm--the holy grail of primary aldosteronism.
Nat Rev Endocrinol. 2011 Oct 18;7(12):697-9. doi: 10.1038/nrendo.2011.180.
10
Prevalence and characteristics of familial hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino-GENetic forms).
Hypertension. 2011 Nov;58(5):797-803. doi: 10.1161/HYPERTENSIONAHA.111.175083. Epub 2011 Aug 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验